RBC Capital analyst Conor McNamara lowered the firm’s price target on Avantor (AVTR) to $33 from $34 and keeps an Outperform rating on the shares. Avantor’s $12M revenue miss on lower applied market sales overshadowed the outperformance in Lab Solutions and bioprocessing, the analyst tells investors in a research note. The firm remains a buyer of the stock on weakness and believes FY25 estimates are achievable.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR:
- Avantor price target lowered to $28 from $30 at Wells Fargo
- Avantor price target lowered to $26 from $28 at Goldman Sachs
- Avantor price target lowered to $25 from $28 at Barclays
- Morning Movers: Capri sinks after judge blocks planned takeover by Tapestry
- Avantor reports Q3 adjusted EPS 26c, consensus 25c